CANN GROUP LIMITED
ASX:CAN
Pharmaceuticals
CANN GROUP LIMITED has not announced a capital raise, but we are collating interest in any future round. Pledge your support and we will let the company know of your interest.
$50k - 100k
< 10
How Fresh Equities Works
1. Create Account
Complete your onboarding digitally in less than 3 minutes.
2. View Terms
View the full term sheet for the capital raise.
3. Bid for Allocation
Submit and track your bid online.
Capital Raise History
Company Overview
Cann Group Limited (CAN) is the first Australian company focused on breeding, cultivating and manufacturing medicinal cannabis for sale and use within Australia. The company hasestablished research and cultivation facilities in Melbourne and is striving to provide access to medicinal cannabis for Australian patients. Cann Group has executed collaboration agreements that will enable it to establish a leading position in plant genetics, breeding, extraction, analysis and production techniques required to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions.
Type
Listed Company
GICS Sub-industry
Pharmaceuticals
Head Office
4 Research Ave, Bundoora VIC 3083, Australia
Website
Quarterly Cash Flows
Directors
Announcements, Interviews, News, and Presentations
More Companies Raising Right Now
Other Companies You Might Like
Archive
Support